眼科手术器械市场报告（2023）：全球市场分析（2022-2028）

最新资讯

本报告提供了有关全球眼科手术器械市场各种可持续发展举措的最新信息，以及 ESCRS 和 AAO 提出的减少一次性器械造成的手术室废物的建议。我是。 关于永续发展的新章节强调了製造商面临的挑战，并包含了新的指标，可以预测他们的努力将对每个产品类别的未来销售产生的影响。

该报告结合了手术过程预测和眼科专业的预测。 我们还列出了创建全球主导供应商的最新收购和合併。

本报告对截至 2023 年的全球眼科手术器械市场（可重复使用和一次性）进行了全面分析，并预测了未来五年的市场表现。 它还讨论了主要趋势、市场驱动因素以及未来成功的关键因素。 本报告概述了全球眼科手术和数量，以及有关白内障手术（最常进行的眼科手术）提供者的详细资讯。 从数量和价值方面预测产品需求，并按产品类别分析市场份额。 市场细分包括31家公司的公司概况（产品、策略市场地位、背景、前景等），并列出了与细分市场相关的85家公司。

目录

本报告旨在为读者提供对可重复使用和一次性仪器市场趋势的理解的深度和背景。 内容如下：

• 可重复使用和一次性眼科手术产品概述。
• 可重复使用和一次性眼科手术产品行业的公司简介。
• 全球白内障发病率和白内障手术统计数据的资讯。
• 全球白内障手术数量的估计和预测（未来五年）。
• 关于屈光水晶体置换手术的考量。
• 有关眼科手术提供者的资讯。
• 美国的 ASC（门诊手术中心）和全球白内障手术提供者。
• 世界各地白内障和青光眼治疗回顾。
• 世界各地眼科医生概论。

What's New:

The new "2023 Ophthalmic Surgical Instruments Market Report" provides the latest coverage of various sustainability initiatives and recommendations from the ESCRS and AAO to reduce operating room waste caused by disposable devices. A new chapter on sustainability looks at the challenges that manufacturers face and includes a new rating scale showing the predicted impact of these initiatives on future sales of each product category.

The report connects our surgical procedure forecast by ophthalmic subspecialty to our forecast for surgical instruments. It also lists the latest company acquisitions and consolidations among market competitors that have created globally dominant providers.

The report provides a comprehensive analysis of the 2023 global market for ophthalmic surgical instruments-both reusable and disposable-and forecasts market performance over the next five years. Important trends, market drivers, and key factors for future success are discussed. The report offers an overview of ophthalmic surgeries and surgery volume worldwide, as well as an in-depth look at providers of cataract surgery, the most commonly performed ophthalmic surgery. Product demand is forecast in units and dollars, and market shares are analyzed by product category. The report profiles 31 market competitors-with discussion of their products, strategic market position, background, and outlook-and lists 85 total companies involved in the market segment.

Contents:

The report is designed to provide depth and context to the reader's understanding of market dynamics in the reusable and disposable instrument market. Coverage includes:

• Descriptions of reusable and disposable ophthalmic surgical products.

• Profiles of companies in the reusable and disposable ophthalmic surgical products industry.

• Information on the global incidence of cataracts and global statistics on cataract surgeries.

• Current estimates and five-year forecasts for cataract surgery volume worldwide.

• Discussion of refractive lens exchange procedures.

• Information on ophthalmic surgery providers.

• US ASCs and cataract surgery providers worldwide.

• Review of global cataract and glaucoma treatment methods.

• Global overview of ophthalmologists.

Author Profile:

William Freeman

Bill Freeman has more than 35 years of experience developing, manufacturing, and marketing cataract surgery products. He has held key executive positions at four firms that produce ophthalmic surgical devices.

Bill's career in ophthalmology began in the 1970s. As president of Cavitron Surgical Systems, he worked with Dr. Charles Kelman in developing and marketing the world's first phacoemulsifier system. While highly controversial in the 1970s, phacoemulsification gradually became the preferred cataract removal technique in the early 1980s. For many years, Cavitron led the cataract instrumentation market.

CooperVision purchased Cavitron in the early 1980s, and Bill joined the company as president of the surgical division. CooperVision expanded its product line to include a wide variety of cataract surgical products-IOLs, viscoelastic solutions, disposable devices, lasers, and custom packs-and became the market leader in many product categories.

In 1989, Alcon acquired CooperVision in an effort to build a strong presence in cataract surgical devices. Bill joined Alcon as general manager of the Irvine Technology Center, where a number of the company's cataract devices, including the Legacy 20000 phacoemulsifier and a broad line of disposable items, were designed and manufactured.

Bill remained with Alcon until 1995. He then joined Mentor Ophthalmics as president of the ophthalmology division. At Mentor, he was responsible for the company's ophthalmic products including IOLs, cautery devices, and surgical instruments.

After leaving Mentor in 1999, Bill joined Market Scope in 2000 and now serves as executive vice president focusing on ophthalmic surgical cataract, retinal and glaucoma devices.